See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Memorial Day
Baseball
Social Media
NCAA
Soccer
Premier League
Cryptocurrency
Donald Trump
Instagram
Artificial Intelligence
Cannes Film Festival
French Open
Published • loading... • Updated

Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®

Summary by Eagle-Tribune
LAVAL, Quebec--(BUSINESS WIRE)--May 23, 2025-

2 Articles

All
Left
Center
2
Right
The Daily NewsThe Daily News
Reposted by
Eagle-TribuneEagle-Tribune
Center

Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®

LAVAL, Quebec--(BUSINESS WIRE)--May 23, 2025-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Eagle-Tribune broke the news in on Friday, May 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Laval, Canada

Laval, Canada

News
For You
SearchBlindspotLocal